Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-

Start of page content Return to search Page to restart searchReturn to Orphan Designation Search PageReturn to Search Page
Generic Name:tetracosactide hexaacetate (beta 1-24-corticotrophin)
Trade Name:Synacthen Depot, S. Retard
Date Designated: 10-31-2012
Orphan Designation:Treatment of infantile spasms
Orphan Designation Status: Designated
FDA Orphan Approval Status:Not FDA Approved for Orphan Indication
Cerium Pharmaceuticals, Inc.
817-B Linsdale Street
Gaithersburg, MD 20878

The sponsor address listed is the last reported by the sponsor to OOPD.

-
-